| scholarly article | Q13442814 |
| P356 | DOI | 10.3727/000000005783983133 |
| P698 | PubMed publication ID | 15929554 |
| P2093 | author name string | Kim KS | |
| Yoon SH | |||
| Kim SU | |||
| Lee MA | |||
| Snyder EY | |||
| Ahn YH | |||
| Cho KG | |||
| Ryu MY | |||
| P2860 | cites work | Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. | Q45890216 |
| Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce l-dopa | Q46578408 | ||
| Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications | Q48088787 | ||
| Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain | Q48210082 | ||
| Multipotent neural cell lines can engraft and participate in development of mouse cerebellum | Q28290006 | ||
| Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line | Q29547239 | ||
| Mammalian neural stem cells | Q29547657 | ||
| Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein | Q31120123 | ||
| Prospects for the clinical application of neural transplantation with the use of conditionally immortalized neuroepithelial stem cells | Q33748682 | ||
| Cell replacement therapies for central nervous system disorders. | Q33921503 | ||
| Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
| "Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain | Q36389958 | ||
| Parkinson's disease: pathophysiology | Q36495393 | ||
| Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin | Q39382909 | ||
| Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease | Q39519102 | ||
| Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model | Q40941898 | ||
| Dopamine turnover and metabolism in the striatum of parkinsonian rats grafted with genetically-modified human astrocytes | Q41035398 | ||
| Stem cells in the central nervous system | Q41116811 | ||
| Neuronal progenitors as tools for cell replacement in the nervous system | Q41235622 | ||
| Fetal nigral transplantation as a therapy for Parkinson's disease | Q41367101 | ||
| Application of ex vivo gene therapy in the treatment of Parkinson's disease | Q41450683 | ||
| Use of retroviral vectors for gene transfer and expression | Q41582824 | ||
| Immortalized neural progenitor cells for CNS gene transfer and repair. | Q41639955 | ||
| L-3,4-dihydroxyphenylalanine synthesis by genetically modified Schwann cells | Q41694260 | ||
| Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer | Q41741592 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| In vivo L-DOPA production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of GTPcyclohydrolase I with tyrosine hydroxylase | Q42828882 | ||
| In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum | Q42831252 | ||
| Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase | Q43185222 | ||
| Gene therapy of experimental brain tumors using neural progenitor cells | Q44761775 | ||
| Neural-targeted gene therapy for rodent and primate hemiparkinsonism | Q45866224 | ||
| P433 | issue | 4 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| neural stem cell | Q2944097 | ||
| P304 | page(s) | 193-202 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Cell Transplantation | Q15761863 |
| P1476 | title | Brain transplantation of neural stem cells cotransduced with tyrosine hydroxylase and GTP cyclohydrolase 1 in Parkinsonian rats | |
| P478 | volume | 14 |
| Q37003823 | Article Commentary: Regenerative Medicine: An Analysis of Cell Transplantation's Impact |
| Q48412934 | BMP and LIF signaling coordinately regulate lineage restriction of radial glia in the developing forebrain |
| Q37795957 | Botanical Drugs and Stem Cells |
| Q36687136 | Cell transplantation: toward cell therapy. |
| Q50534121 | Clinical potential of intravenous neural stem cell delivery for treatment of neuroinflammatory disease in mice? |
| Q39392953 | Comparison of red-shifted firefly luciferase Ppy RE9 and conventional Luc2 as bioluminescence imaging reporter genes for in vivo imaging of stem cells. |
| Q39381738 | Different effects of histone deacetylase inhibitors nicotinamide and trichostatin A (TSA) in C17.2 neural stem cells |
| Q48949745 | Frontiers in Neural Transplantation and Repair: A Special Issue Based on the 11th ASNTR Meeting. |
| Q35217437 | Identification of a neuronal gene expression signature: role of cell cycle arrest in murine neuronal differentiation in vitro |
| Q39898054 | Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease |
| Q37494307 | Intracerebral transplantation of neural stem cells combined with trehalose ingestion alleviates pathology in a mouse model of Huntington's disease. |
| Q34332113 | Maintenance and neuronal cell differentiation of neural stem cells C17.2 correlated to medium availability sets design criteria in microfluidic systems |
| Q38079295 | Neural stem cell-based treatment for neurodegenerative diseases |
Search more.